Angela Bilkhu

Angela Bilkhu

Angela Bilkhu is the Senior Director in the Global Patients Network Team and is the Clinical Research Strategy and Engagement Catalyst.

Angela Bilkhu joined Roche Canada in 2018 as a Senior Manager within the Federal Government Relations and Policy Team. In this role, she focused on supporting policy and access priorities in rare diseases, oncology, and neurosciences, while fostering strong relationships with key stakeholders—including policymakers and the patient community—to shape Roche Canada’s policy tools and strategies.

In 2020, Angela transitioned to the Global Patient Partnership Team to take on a newly created role focused on patient-centric research and development in the solid tumour space. She collaborated closely with cross-functional teams and the patient community to ensure R&D efforts were inclusive of patient perspectives and needs. In 2022, Angela moved to the hematology franchise, assuming responsibilities for the Sickle Cell Disease and aHUS patient communities. She also took on an above-disease-area role as the Clinical Research Strategy and Engagement Catalyst to embed patient inclusivity into Roche’s drug development governance and operational frameworks.

Angela has a bachelor’s degree in Science and Biotechnology from Carleton University, Ottawa, Ontario, Canada.